Literature DB >> 31173257

Identification of tRNA‑derived fragments in colon cancer by comprehensive small RNA sequencing.

Wei Xiong2, Xiaoli Wang1, Xinyi Cai2, Wei Xiong2, Yan Liu1, Cheng Li1, Qiuyan Liu1, Jiyong Qin1, Yunfeng Li2.   

Abstract

Transfer RNA‑derived fragments (tRFs) are a novel class of small non‑coding RNAs that are abundant in various species and have been implicated in human diseases. However, to the best of our knowledge, the role of tRFs in colon cancer has not been explored. In the present study, a comprehensive analysis was conducted to identify the tRFs associated with colon cancer and predict their roles in colon carcinogenesis. tRFs and miRNAs that were differentially expressed (DE) between colon cancer and matched peritumor tissues were identified by small RNA sequencing. DE mRNAs were screened by Gene Expression Profiling Interactive Analysis. DE microRNAs (miRNAs) reported to be associated with colon cancer were selected as key miRNAs. The targets of the DE tRFs and key miRNAs were predicted using MiRanda and RNAhybrid, respectively. The potential targets that were common to and negatively correlated with the DE tRFs and key miRNAs were screened. The DE mRNAs and potential targets were subjected to Gene Ontology and pathway analyses, respectively. In total, 16 DE tRFs, 26 DE miRNAs, and 5,327 DE mRNAs were identified. Five of the 26 DE miRNAs were selected as key miRNAs. DE mRNAs were mainly enriched in cell proliferation‑related processes and pathways. Fifty‑five DE mRNAs were potential targets of both DE tRFs and key miRNAs and were primarily enriched in vitamin metabolic pathways and the cyclic guanine monophosphate‑protein kinase G signaling pathway. Collectively, these results suggest that tRFs may play crucial roles in the development of colon cancer. This study could provide valuable cues for further research into the roles of tRFs in colon cancer.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31173257     DOI: 10.3892/or.2019.7178

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  14 in total

1.  Study of tRNA-Derived Fragment tRF-20-S998LO9D in Pan-Cancer.

Authors:  Jinqi Ma; Fengxia Liu
Journal:  Dis Markers       Date:  2022-05-05       Impact factor: 3.464

2.  High Expression of a tRNAPro Derivative Associates with Poor Survival and Independently Predicts Colorectal Cancer Recurrence.

Authors:  Panagiotis Tsiakanikas; Panagiotis G Adamopoulos; Dimitra Tsirba; Pinelopi I Artemaki; Iordanis N Papadopoulos; Christos K Kontos; Andreas Scorilas
Journal:  Biomedicines       Date:  2022-05-12

Review 3.  Non-coding RNAs as emerging regulators and biomarkers in colorectal cancer.

Authors:  Chandra Kishore; Devarajan Karunagaran
Journal:  Mol Cell Biochem       Date:  2022-03-24       Impact factor: 3.396

Review 4.  Action mechanisms and research methods of tRNA-derived small RNAs.

Authors:  Yaoyao Xie; Lipeng Yao; Xiuchong Yu; Yao Ruan; Zhe Li; Junming Guo
Journal:  Signal Transduct Target Ther       Date:  2020-06-30

Review 5.  tRNA-derived RNA fragments in cancer: current status and future perspectives.

Authors:  Mengqian Yu; Bingjian Lu; Jisong Zhang; Jinwang Ding; Pengyuan Liu; Yan Lu
Journal:  J Hematol Oncol       Date:  2020-09-04       Impact factor: 17.388

Review 6.  Transfer RNA-derived small RNAs: potential applications as novel biomarkers for disease diagnosis and prognosis.

Authors:  Yang Jia; Wei Tan; Yedi Zhou
Journal:  Ann Transl Med       Date:  2020-09

7.  tRNALys-Derived Fragment Alleviates Cisplatin-Induced Apoptosis in Prostate Cancer Cells.

Authors:  Changwon Yang; Minkyeong Lee; Gwonhwa Song; Whasun Lim
Journal:  Pharmaceutics       Date:  2021-01-04       Impact factor: 6.321

8.  Differential Expression Profiles and Function Prediction of Transfer RNA-Derived Fragments in High-Grade Serous Ovarian Cancer.

Authors:  Buze Chen; Sicong Liu; Haihong Wang; Guilin Li; Xiaoyuan Lu; Hao Xu
Journal:  Biomed Res Int       Date:  2021-03-30       Impact factor: 3.411

9.  Elucidating the Role of Serum tRF-31-U5YKFN8DYDZDD as a Novel Diagnostic Biomarker in Gastric Cancer (GC).

Authors:  Yuejiao Huang; Haiyan Zhang; Xinliang Gu; Shiyi Qin; Ming Zheng; Xiangrong Shi; Chunlei Peng; Shaoqing Ju
Journal:  Front Oncol       Date:  2021-08-23       Impact factor: 6.244

10.  tRF3008A suppresses the progression and metastasis of colorectal cancer by destabilizing FOXK1 in an AGO-dependent manner.

Authors:  Ying Han; Yinghui Peng; Shanshan Liu; Xinwen Wang; Changjing Cai; Cao Guo; Yihong Chen; Le Gao; Qiaoqiao Huang; Min He; Edward Shen; Jie Long; Jian Yu; Hong Shen; Shan Zeng
Journal:  J Exp Clin Cancer Res       Date:  2022-01-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.